We know that some people suffer from a genetic disorder called the syndrome.
But what about the symptoms?
Some sufferers can be described as a lucky person, who are not able to detect the presence of a genetic disease, according to Dr Rakesh Jain from Oxford University’s Department of Medicine.
This is because there is a genetic component to some of their symptoms.
We have seen many new medicines designed to treat the genetic disease but this has not made it easy for the sufferers to detect these treatments.
Dr Jain has been researching the molecular mechanisms underlying the genetic disorder.
« What I have discovered is that there is something called the RNA-Seq mechanism which tells us that a genetic mutation is involved in the disorder, » he told New Scientist.
The RNA-seq process involves sequencing the DNA of the organism and then analyzing the sequence of these sequences to identify a sequence that contains a genetic alteration.
There are now many drugs available to treat genetic disorders.
However, it is not known if they all work equally, and there are also several drugs that can only be prescribed to people who have the genetic mutation.
In an effort to solve this issue, Dr Jain and his team at Oxford have developed a drug that can be administered to people with a genetic defect.
They have now published their results in Nature Medicine, describing the results as a first-of-its-kind drug for the treatment of genetic diseases.
According to Dr Jains team, the new drug was created using a protein called P2X, which encodes a receptor for the drug, which allows it to bind to the RNA and stop the protein from being turned on by the RNA.
It is hoped the drug will allow for faster treatment of these diseases.